HK Stock MarketDetailed Quotes

02633 JACOBSON PHARMA

Watchlist
  • 0.570
  • 0.0000.00%
Market Closed Apr 19 16:08 CST
1.14BMarket Cap4.25P/E (TTM)

About JACOBSON PHARMA Company

The Group is a leading pharmaceutical company in Hong Kong, engaged in vertically integrated R&D, production, sales and distribution of basic and specialty drugs. As a major generic drug supplier in Hong Kong, the Group has one of the broadest sales and distribution coverage in the Hong Kong market, covering the public and private sectors in Hong Kong, and is actively expanding into selected strategic markets in Asia. The Group has a rich product portfolio and is in a leading position in the market in various treatment categories. Currently, it operates 10 licensed pharmaceutical product production facilities in Hong Kong. The Group invests heavily in its commercial infrastructure and manages its own warehousing, logistics, supervision, quality control, and sales and marketing operations. Our integrated warehousing facilities supported by the SAP system are located in Hong Kong's transportation hubs, which help ensure high supply chain efficiency and flexibility to provide customers with logistics solutions.

Company Profile

Symbol02633
Company NameJACOBSON PHARMA
ISINKYG677291067
Listing DateSep 21, 2016
Issue Price1.50
Shares Offered437.50M share(s)
FoundedFeb 16, 2016
Registered AddressCayman Islands
Chairmanguangye cen
Secretaryzhenqiu yu
Audit InstitutionKPMG
Company CategoryOther
Registered OfficeCricket Square, Hutchins Drive PO Box 2681, Grand Cayman KY1-1111, Cayman Islands
Head Office and Principal Place of BusinessRoom 2313-18, 23rd Floor, Block 1, Millennium City 1, 388 Kwun Tong Road, Kwun Tong, Kowloon, Hong Kong
Fiscal Year Ends03-31
Employees1588
MarketHong Kong motherboard
Phone(852)22672298
Emailjacobsonpharma@sprg.com.hk
Business Jacobson Research Pharmaceutical Co., Ltd. is a Hong Kong company that manufactures and trades generic and proprietary Chinese medicines. The company operates through two major divisions. The Generic Medicine segment develops, produces and distributes generic drugs for therapeutic use. Currently, the division's business is mainly carried out in Hong Kong, China. The Proprietary Chinese Medicine segment develops, manufactures and distributes traditional Chinese medicines. Currently, the division's business is mainly carried out in Hong Kong, China.

Company Executives

  • Name
  • Position
  • Salary
  • guangye cen
  • CEO,presidencies,Executive Director,Chairman of the Executive Committee,Founder of the Group
  • 13.69M
  • zhenliang yan
  • Executive Director,Nomination Committee Members,Executive Committee Members,Authorized Representative
  • 8.03M
  • yuhui pan
  • Vice President — Administration,Executive Director,Remuneration Committee Members,Executive Committee Members,Authorized Representative
  • 4.53M
  • zhiji huang
  • Non-executive directors,Member of the Scientific Advisory Board
  • 226.00K
  • jiongtang lin
  • Independent Non-Executive Director,Remuneration Committee Chairman,Nomination Committee Members,Audit Committee Members
  • 226.00K
  • junwen yang
  • Independent Non-Executive Director,Chairman of the Audit Committee,Chairman of the Nomination Committee,Remuneration Committee Members
  • 226.00K
  • chengguang lin
  • Independent Non-Executive Director,Chairman of the Risk Management Committee,Audit Committee Members
  • 226.00K
  • zhenqiu yu
  • Company Secretary
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
%Chg